Arch Biopartners Inc. (8HA)
FSX
Closed
Aug 26, 2026
Day's Range
0.597052 wk Range
0.2495Overview - 8HA - Arch Biopartners Inc.
Key Statistics
Valuation
Enterprise Value
28.66M
P/E (Trailing)
‪-24.87‬
PEG Ratio
‪1.11‬
Price / Sales (TTM)
‪256.55‬
Price / Book
‪-10.96‬
EV / EBITDA
‪-23.08‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-1,418.63%‬
Return on Assets
‪-276.77%‬
Return on Equity
‪40.00%‬
Ownership
Shares Outstanding
67.72M
Float
53.52M
Held by Insiders
‪18.29%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪1.72‬
50-Day Avg
‪0.5034‬
200-Day Avg
‪0.4440‬
Dividends
Payout Ratio
‪0.00%‬
Peers - 8HA - Arch Biopartners Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
Profile Summary - 8HA - Arch Biopartners Inc.
About
Arch Biopartners Inc. is a Canadian therapeutic biotechnology company focused on developing novel drug candidates to prevent and treat kidney-related injury and disease. Headquartered in Toronto, it concentrates on both acute kidney injury and chronic kidney disease, conditions that represent a significant burden in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
